“You Have a 50% Coronary Artery Blockage” — What That Actually Means

I initially set out to write a straightforward blog post explaining what it means when a doctor says you have a 50% coronary artery blockage. It’s a topic that often confuses patients and clinicians, and I thought a clear explanation would be helpful.

But as I began drafting, I realized that listing percentages and medical jargon felt dry and disconnected. It lacked the human element—the real-life experiences behind those numbers.

So, I decided to take a different approach. Instead of a clinical breakdown, I’m sharing a story. A story that brings those percentages to life, illustrating what they mean in the context of a person’s journey. Through this narrative, I hope to shed light on the complexities of coronary artery narrowing in an informative and relatable way.

The Confusing Comfort of Percentages

She wasn’t expecting the shortness of breath.

It had started two months earlier—subtle at first. She chalked it up to winter, stress, or maybe the extra weight she’d been carrying since her last birthday. But when she found herself winded after two flights of stairs, she did something uncharacteristic.

She made an appointment.

Her name was Sofia Cardona. At fifty-seven, she had weathered life’s storms with a blend of resilience and wit. A former smoker who now practiced yoga sporadically, she ran a modest graphic design business from her home in Valoria. Her kitchen bore the marks of her culinary adventures—a testament to her belief that the right olive oil could elevate any dish.

A few days later, Sofia was lying beneath the quiet whir of a CT scanner, eyes closed, heart tapping a steady rhythm as contrast dye moved through her bloodstream. She was undergoing CT Coronary Angiography (CCTA), a noninvasive test used to visualize the coronary arteries and detect plaque or narrowing.

The results came back quickly.

Her cardiologist, a man named Dr. Alaric Duvall—kind eyes, quiet hands—leaned back in his chair and said, “There’s a 50% narrowing in your left anterior descending artery.”

Sofia blinked. “Fifty percent?”

“It’s moderate,” he said. “Nothing we need to treat with a stent. No need for anything invasive at this point.”

She nodded slowly. She was good at nodding when she didn’t understand. Half blocked. That didn’t sound so bad. Still usable. Like a road with one lane closed.

But later that evening, sitting at her kitchen table, the phrase kept circling in her mind.

Fifty percent of what?

She opened her laptop.

And so it began.

Measuring the Squeeze

By the time Sofia reached page six of her Google search, she realized something unsettling: she didn’t actually understand what 50% stenosis meant.

Every article seemed to say something slightly different. Some mentioned blood flow. Others talked about diameter. A few threw around terms like “non-obstructive” and “intermediate lesion” as if everyone casually used those over breakfast.

She closed her laptop with a sigh and picked up her phone.

“Alexa,” she said. “You’ve got a smart heart. What does 50% blockage mean?”

Her best friend answered on the second ring. “Great. I’m your personal cardiology assistant now”.

They laughed. Sofia quickly explained—the scan, the number, the doctor’s calm tone that somehow left her more confused than reassured.

Alexa was a seasoned cath lab nurse with years of experience assisting in cardiac catheterizations and interpreting angiographic findings.

“Look,” she said, “in the cath lab, we often see varying degrees of narrowing in coronary arteries. A 50% stenosis is generally considered moderate and typically isn’t enough to cause significant problems because it’s not flow-limiting. Blood can usually get through without much issue.”

Sofia paused. “So, it’s not that serious?”

“Not necessarily. It’s important to consider the whole picture. A 70% narrowing might start to impede blood flow, especially during exertion, and a 90% blockage is almost certainly flow-limiting and more concerning. But these numbers are part of a broader context. We also look at the patient’s symptoms, the specific artery involved, and other factors.”

Illustration showing 50%, 70%, and 90% coronary artery stenosis for comparison; increasing narrowing reflects growing risk of flow limitation and ischemia.
Visual comparison of coronary artery stenosis severity. From left to right: 50% narrowing (moderate), 70% narrowing (severe and often flow-limiting), and 90% narrowing (critical stenosis with high risk of ischemia). While higher-grade lesions can restrict blood flow, even moderate plaques may rupture and cause acute events.

Sofia’s eyebrows rose. “So, the percentage alone doesn’t tell the whole story?”

“Exactly,” Alexa replied. “That’s why cardiologists often use additional tests, like stress tests or fractional flow reserve measurements, to determine if a blockage is actually affecting blood flow. It’s not just about the percentage; it’s about how that narrowing impacts the heart’s function.”

Sofia nodded slowly. “That makes sense. Thanks for breaking it down.”

Where Do These Numbers Even Come From?

The next morning, Sofia emailed the cardiology clinic.

Subject: Follow-up on CT scan
Body: Hi—I’d like a copy of my scan report if possible. Just curious to see the details. Thanks, Sofia Cardona.

She didn’t expect a reply that fast.

By lunchtime, she had it. A neat, three-page PDF. She scrolled past her name, past the legalese and disclaimers, and landed on a phrase that made her squint.

CAD-RADS 3 – Moderate stenosis (50–69%) in proximal LAD.

There it was again. “50 to 69.” Not even a firm number—just a range.

And what was CAD-RADS? It sounded like something NASA would use to describe a satellite malfunction.

Back on Google, she learned it stood for Coronary Artery Disease – Reporting and Data System—a way for radiologists to categorize findings in coronary CT angiography. Like putting arteries into folders: mild, moderate, severe.

CAD-RADS 3 meant her plaque was in the “moderate” zone. It didn’t tell her if it was dangerous. Just that it existed.

And as for that 50% number? That could come from one of two places:

  • Sometimes, it was calculated digitally—comparing the narrowest part of the artery to a “normal” section just upstream or downstream.
  • But more often—especially in invasive angiography—it was eyeballed. Estimated. Visually guessed by an experienced physician.

Sofia stared at the phrase again. “Estimated visually.”

Her inner designer cringed. She made her living pixel-perfect. Fonts off by 3% made her itch. And now she was learning that something as serious as a coronary narrowing might be called “50-69%” based on someone’s eyeball?

Maybe it was an informed guess. But it still felt… fuzzy.

And yet, that one fuzzy number was now shaping how everyone, including her, thought about her heart.

It’s Not Just the Size—It’s the Location.

📘 CAD-RADS Classification: Coronary Artery Disease Reporting System
CAD-RADS is a standardized system for reporting coronary artery disease severity on coronary CT angiography (CCTA). It categorizes the most severe narrowing in any major coronary artery and guides further testing or treatment decisions.
CAD-RADSStenosis Severity
0No plaque or stenosis
1Minimal stenosis (1–24%)
2Mild stenosis (25–49%)
3Moderate stenosis (50–69%)
4ASevere stenosis (70–99%)
4BLeft main ≥50% stenosis
5Total occlusion (100%)
Modifiers: Letters may be added to describe additional findings:
V = Vulnerable plaque features (e.g., low attenuation)
S = Presence of coronary stents
G = Coronary artery bypass grafts
N = Non-diagnostic segments
Sofia had a label now—CAD-RADS 3—but the more she read, the more she sensed that “moderate stenosis” wasn’t as simple as it sounded. It depended on where the plaque was, what it was made of, and what it might do next.
It’s Not Just the Percentage – It’s the Location?

Sofia didn’t intend to delve deeper into medical research, but curiosity nudged her forward. Her report mentioned a “50-69% stenosis in the proximal LAD,” and while she now understood that this might not be immediately alarming, the term “proximal LAD” lingered in her mind.

She reached out to Alexa again.

“Hey, Alexa,” Sofia began, “I was reading about the LAD artery. It’s referred to as the ‘widowmaker‘?”

Alexa, drawing from her years as a cath lab nurse, responded, “Yes, the LAD—left anterior descending artery—supplies a significant portion of the heart muscle. A blockage here, especially in the proximal segment, can be particularly concerning.”

Sofia’s heart skipped a beat. “But mine’s only 50% narrowed. That doesn’t sound too bad, right?”

“True,” Alexa reassured her. “A 50% narrowing isn’t typically flow-limiting. However, because it’s in the proximal LAD, we monitor it more closely. The location adds a layer of significance.”

Sofia pondered this. “So, it’s not just about how much the artery is narrowed, but where it’s narrowed?”

“Exactly,” Alexa affirmed. “Think of the coronary arteries like a tree. The left main artery is the trunk, and it branches into the LAD and circumflex arteries, which further branch out. A 60% narrowing in the left main artery is more concerning than a 90% blockage in a small side branch because the left main supplies a larger area of the heart. The area at risk is greater.”

Sofia nodded, absorbing the information. She realized that understanding her condition wasn’t solely about percentages but also about the context—where the blockage was and how it might affect her heart’s function.

The Second Opinion

Getting the appointment hadn’t been easy. Dr. Elena Marquez was one of those cardiologists everyone seemed to know by reputation—clinical, exacting, and booked solid for months. But somehow, the referral went through. And now, here she was.

She entered with quiet precision—dark hair streaked with silver, pulled into a low knot. Her white coat was immaculate, her hazel eyes focused and unreadable. She didn’t waste time with small talk.

“Fifty percent stenosis is a number, she said, eyes on the chart, then on Sofia. “It’s not the whole story. What matters is how your heart functions.

Sofia hesitated. “So… it’s not serious?”

Dr. Marquez didn’t blink.
“It might be. Or it might be nothing. That’s why we test.” 

A stress echocardiogram.

They moved quickly. First, a resting echocardiogram—Sofia lying on the narrow exam table while the technician rolled a probe across her chest. Her heart appeared in flickering gray and black, valves opening and closing like mechanical doors.

Then came the treadmill—brief, controlled, enough to raise her heart rate. The moment she stepped off, she was back on the table. Another round of images, this time while her heart pounded hard against her ribs. The probe pressed under her sternum. Dr. Marquez stood behind the monitor, arms crossed, silent.

When it was done, she spoke with clinical finality.

“No ischemia. No wall motion abnormalities. Your heart handled stress normally.”

📘 What Is Ischemia?
Ischemia refers to a lack of oxygen-rich blood flow to a part of the body. In cardiology, it usually means that the heart muscle isn’t getting enough blood—typically due to narrowed coronary arteries. Ischemia can occur during physical activity or emotional stress and may cause symptoms like chest pain, shortness of breath, or fatigue. Sometimes, it happens without any symptoms at all.

Sofia exhaled. She didn’t realize she’d been holding her breath.

“You do have coronary artery disease,” Marquez added. “There’s plaque in the LAD. But it’s not limiting blood flow. You don’t need coronary angiography. You don’t need a stent.”

Sofia blinked. “So I’m okay?”

Marquez gave her a measured look.
“You’re stable. That’s not the same thing as ‘okay.’ It means there’s a disease, but it’s not obstructing flow. Not yet.”

She sat down, folding her hands. Her voice was calm, direct.

“Exercise-induced ischemia is what we’re looking for. It means that when your heart works harder, the narrowed artery can’t deliver enough oxygen-rich blood. That’s when symptoms happen. That’s when risk increases. But you didn’t show signs of that.”

Sofia nodded slowly. It was a lot to take in.

“So what now?”

“We treat the disease—not with stents, but with risk reduction,” Marquez said. “Lifestyle, medication, close follow-up. The goal is to keep that plaque from growing, rupturing, or causing trouble. You don’t fix this with hardware. You fix it by staying ahead of it.”

There was no hand-holding. No sugarcoating.

But for the first time, Sofia felt like someone wasn’t just treating a number. They were treating her.

Beneath the Surface

Dr. Marquez wasn’t finished yet.

“We don’t treat plaque just because it exists,” she said, pulling up Sofia’s coronary CT on the screen. “We treat risk. And to do that properly, we have to look beyond the number.”

She zoomed in on the LAD segment.

“Here.” She tapped the monitor. “Fifty percent narrowing. But that’s not what I’m looking at. I’m looking at what it’s made of.”

Sofia stared at the grayscale image. It meant nothing to her—just shadows and angles. But to Marquez, it was a story in motion.

“That’s soft plaque—low attenuation, with some positive remodeling. That combination suggests inflammation. Instability.”

“So it’s not just how narrow it is?” Sofia asked.

“Not always,” Marquez said. “You can have a 30% lesion rupture and cause a major heart attack. Meanwhile, someone else can live their whole life with a 70% calcified plaque and never know it.”

Sofia frowned. “What’s the difference?”

Calcium means maturity,” she said. “Stable plaques tend to calcify over time. That’s what the calcium score picks up. But it doesn’t see soft plaque. It tells you where you’ve been, not necessarily where you’re going.”

Sofia’s mind went back to her Google searches. Coronary artery calcium—the so-called “heart scan.” Some websites made it sound definitive.

“So a high calcium score means you’ve got disease, but maybe not danger?”

Marquez nodded. “Right. It correlates with long-term risk. It’s a marker of total plaque burden. But it doesn’t tell you if that plaque is likely to rupture today.”

Total plaque burden, she explained, was the total amount of plaque in all the coronary arteries—not just one narrowing in one location. A person could have several mild plaques scattered across multiple arteries and still be at high risk, simply because of the cumulative load. The danger wasn’t always about a single tight spot. It was about the overall landscape.

📘 What Is Plaque Burden?

Plaque burden refers to the total amount of atherosclerotic plaque present throughout the coronary arteries—not just in one spot. Even if no single narrowing is severe, a high overall plaque burden increases the risk of future heart events. CT angiography and calcium scoring can help estimate this burden by showing both calcified and non-calcified plaque.

She pointed again to the CT image.

“This plaque isn’t heavily calcified. That’s what concerns me. You’re not obstructed, but you’re vulnerable.”

Sofia looked at the screen again.
The number—50%—had lost its grip on her imagination.
Now it was the texture. The character. The volatility of it all.

“So this is still coronary artery disease.”

“Yes,” Marquez said. “Just not the kind that shows up on a stress test. Not yet.”

“And the calcium score?”

“Yours was low. Which isn’t meaningless. It means there’s not much calcified plaque. But that doesn’t rule out soft plaque. It’s why we look at anatomy and function together.”

The real threat lay not just in the narrowing itself, but in the location of the plaque, the total burden across the coronary tree—and what might happen next.

Not the Percentage. It’s the Risk

We’ve been taught to fear the blockage.

A “50% narrowing” sounds ominous. A “calcium score of 300” sounds like a countdown. But if we’ve learned anything, it’s this:

It’s not the percentage that predicts the problem. It’s the plaque—and how it behaves.

Here’s what really matters:

  • Most heart attacks don’t come from severe blockages.
    They come from unstable plaques—often mild narrowings—filled with soft, inflamed material that ruptures unexpectedly.

  • A normal stress test doesn’t mean no risk.
    Stress tests detect flow-limiting lesions. But soft plaque can rupture without ever having restricted flow. That’s why anatomical imaging, like CT angiography, matters—especially when we’re assessing risk, not just symptoms.

  • A high calcium score tells us there’s disease. A low one doesn’t guarantee safety.
    Calcification means the disease is there, but often stable. Soft plaques, especially in younger patients, may not show up on a calcium scan at all, but they can still be dangerous.

  • We don’t stent plaques because they exist.
    We reserve stenting for those who cause symptoms or ischemia. Stable plaques are treated medically with lifestyle, lipid-lowering therapy, and inflammation control.

  • We’ve moved beyond the old model.
    Coronary artery disease is no longer just about pipes and blockages. It’s a dynamic, inflammatory process. And understanding the nature of the plaque—its vulnerability, its composition—is now at the heart of modern prevention.

So next time someone tells you they have “a 50% blockage,” the better question isn’t how much.

It’s: What kind? Where is it? And is it trying to kill you—or just quietly sitting there?

The goal isn’t to fear plaque. It’s to understand it. And stay ahead of it.

📚 References
  1. Libby P, Ridker PM, Hansson GK. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol. 2009;54(23):2129–2138.
  2. Motoyama S, Sarai M, Harigaya H, et al. Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes. J Am Coll Cardiol. 2007;50(4):319–326.
  3. Budoff MJ, Young R, Burke AP, et al. Coronary artery calcium scoring: 2022 expert consensus statement from the Society of Cardiovascular Computed Tomography. J Cardiovasc Comput Tomogr. 2022;16(2):e101–e120.
  4. Cury RC, Abbara S, Achenbach S, et al. CAD-RADS™ Coronary Artery Disease – Reporting and Data System: an expert consensus document of SCCT, ACR, and NASCI. J Am Coll Radiol. 2016;13(12 Pt A):1458–1466.
  5. Stone GW, Maehara A, Lansky AJ, et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011;364(3):226–235.
  6. Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41(3):407–477.
  7. Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies. Circulation. 2003;108(14):1664–1672.
  8. Shah PK. Mechanisms of plaque vulnerability and rupture. J Am Coll Cardiol. 2003;41(4 Suppl S):15S–22S.
  9. Nicholls SJ, Tuzcu EM, Kalidindi S, et al. Effect of statins on progression of coronary atherosclerosis in patients with low levels of LDL cholesterol: the ASTEROID trial. JAMA. 2006;295(13):1556–1565.
  10. Bittencourt MS, Hulten EA, Ghoshhajra B, et al. Prognostic value of nonobstructive coronary artery disease detected by coronary computed tomography angiography. Circulation. 2014;129(7):713–723.
  11. Hecht HS. Coronary artery calcium scoring: past, present, and future. JACC Cardiovasc Imaging. 2015;8(5):579–596.
  12. Hoffmann U, Ferencik M, Udelson JE, et al. Prognostic value of noninvasive cardiovascular testing in patients with stable chest pain: insights from the PROMISE trial. JAMA Cardiol. 2016;1(9):939–948.
  13. Boden WE, O’Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356(15):1503–1516.
  14. Maron DJ, Hochman JS, Reynolds HR, et al. Initial invasive or conservative strategy for stable coronary disease. N Engl J Med. 2020;382(15):1395–1407.
  15. Arbab-Zadeh A, Fuster V. The myth of the “vulnerable plaque”: transition from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment. J Am Coll Cardiol. 2015;65(8):846–855.

This article was developed with editorial assistance from ChatGPT, an AI language model developed by OpenAI, to help refine structure, tone, and clarity.


Discover more from Doc's Opinion

Subscribe to get the latest posts sent to your email.

RSS
Follow by Email